In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases

被引:276
作者
Patricelli, Matthew P. [1 ]
Nomanbhoy, Tyzoon K. [1 ]
Wu, Jiangyue [1 ]
Brown, Heidi [1 ]
Zhou, David [1 ]
Zhang, Jianming [2 ,3 ]
Jagannathan, Subadhra [1 ]
Aban, Arwin [1 ]
Okerberg, Eric [1 ]
Herring, Chris [1 ]
Nordin, Brian [1 ]
Weissig, Helge [1 ]
Yang, Qingkai [4 ]
Lee, Jiing-Dwan [4 ]
Gray, Nathanael S. [2 ,3 ]
Kozarich, John W. [1 ]
机构
[1] ActivX Biosci, La Jolla, CA 92037 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[4] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
来源
CHEMISTRY & BIOLOGY | 2011年 / 18卷 / 06期
关键词
GROWTH-FACTOR RECEPTOR; P38 MAP KINASE; B-RAF KINASE; TYROSINE KINASE; PROTEOMICS STRATEGY; TUMOR PROGRESSION; PROTEIN-KINASES; INHIBITORS; POTENT; BRAF;
D O I
10.1016/j.chembiol.2011.04.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinases are intensely studied mediators of cellular signaling, yet important questions remain regarding their regulation and in vivo properties. Here, we use a probe-based chemoprotemics platform to profile several well studied kinase inhibitors against >200 kinases in native cell proteomes and reveal biological targets for some of these inhibitors. Several striking differences were identified between native and recombinant kinase inhibitory profiles, in particular, for the Raf kinases. The native kinase binding profiles presented here closely mirror the cellular activity of these inhibitors, even when the inhibition profiles differ dramatically from recombinant assay results. Additionally, Raf activation events could be detected on live cell treatment with inhibitors. These studies highlight the complexities of protein kinase behavior in the cellular context and demonstrate that profiling with only recombinant/purified enzymes can be misleading.
引用
收藏
页码:699 / 710
页数:12
相关论文
共 44 条
[1]   Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors [J].
Bantscheff, Marcus ;
Eberhard, Dirk ;
Abraham, Yann ;
Bastuck, Sonja ;
Boesche, Markus ;
Hobson, Scott ;
Mathieson, Toby ;
Perrin, Jessica ;
Raida, Manfred ;
Rau, Christina ;
Reader, Valerie ;
Sweetman, Gavain ;
Bauer, Andreas ;
Bouwmeester, Tewis ;
Hopf, Carsten ;
Kruse, Ulrich ;
Neubauer, Gitte ;
Ramsden, Nigel ;
Rick, Jens ;
Kuster, Bernhard ;
Drewes, Gerard .
NATURE BIOTECHNOLOGY, 2007, 25 (09) :1035-1044
[2]   Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib [J].
Carey, Kendall D. ;
Garton, Andrew J. ;
Romero, Maria S. ;
Kahler, Jennifer ;
Thomson, Stuart ;
Ross, Sarajane ;
Park, Frances ;
Haley, John D. ;
Gibson, Neil ;
Sliwkowski, Mark X. .
CANCER RESEARCH, 2006, 66 (16) :8163-8171
[3]  
Cohen MH, 2002, CLIN CANCER RES, V8, P935
[4]   Protein kinases - the major drug targets of the twenty-first century? [J].
Cohen, P .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :309-315
[5]   SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1 [J].
CUENDA, A ;
ROUSE, J ;
DOZA, YN ;
MEIER, R ;
COHEN, P ;
GALLAGHER, TF ;
YOUNG, PR ;
LEE, JC .
FEBS LETTERS, 1995, 364 (02) :229-233
[6]   Options and considerations when selecting a quantitative proteomics strategy [J].
Domon, Bruno ;
Aebersold, Ruedi .
NATURE BIOTECHNOLOGY, 2010, 28 (07) :710-721
[7]   Spontaneous autophosphorylation of Lyn tyrosine kinase at both its activation segment and C-terminal tail confers altered substrate specificity [J].
Donella-Deana, A ;
Cesaro, L ;
Ruzzene, M ;
Brunati, AM ;
Marin, O ;
Pinna, LA .
BIOCHEMISTRY, 1998, 37 (05) :1438-1446
[8]  
García-Echeverría C, 2000, MED RES REV, V20, P28, DOI 10.1002/(SICI)1098-1128(200001)20:1<28::AID-MED2>3.3.CO
[9]  
2-U
[10]   Organization and regulation of mitogen-activated protein kinase signaling pathways [J].
Garrington, TP ;
Johnson, GL .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) :211-218